Organisms survive by maintaining equilibrium with ters. Glucocorticoids also modulate the growth, reproductive and thyroid axes. Abnormalities of their environment. The stress system is critical to this homeostasis. Glucocorticoids modulate the stress system activation have been shown in inflammatory diseases such as rheumatoid arthritis, as well stress response at a molecular level by altering gene expression, transcription, and translation, among as behavioural syndromes such as melancholic depression. These disorders are comparable to those other pathways. The effect is the inhibition of the functions of inflammatory cells, predominantly seen in rats whose CRH system is genetically abnormal. Thus, the stress response is central to resistance mediated through inhibition of cytokines, such as IL-1, IL-6, and TNF-a. The central effectors of the to inflammatory and behavioural syndromes. In this review, we describe the response to stress at stress response are the corticotrophin-releasing hormone (CRH) and locus coeruleus-norepinephrine molecular, cellular, neuroendocrine and behavioural levels, and discuss the disease processes that result (LC-NE)/sympathetic systems. The CRH system activates the stress response and is subject to modufrom a dysregulation of this response, as well as recent developments in their treatment. lation by cytokines, hormones, and neurotransmit-
Introduction
Organisms survive by maintaining a dynamic equilibare the peripheral limbs of the stress system. Increased system activation as a result of stress leads rium with their environment. The organization of this homeostasis exists at molecular, cellular, physioto central and peripheral changes, which facilitate behavioural adaptation and redirection of energy to logical and behavioural levels. Stress is a state of threat to this equilibrium, and adaptation to stress, the central nervous system, muscle, and stressed body sites. These changes serve to promote or allostasis, confers a survival advantage. Successful adaptation requires not only the ability to respond homeostasis. HPA axis activation results in glucocorticoid secretion. The principal role of glucocorticoids to stress, but also the ability to control the stress response appropriately.
during the stress response is thought to be restraint of the effectors of the stress response. This stress system is tonically active, but both physical and emotional stressors that exceed a critical
We review the response to stress from a molecular to a behavioural level and discuss the disease prothreshold increase its activity further. The hypothalamic-pituitary-adrenal (HPA) axis and the sympacesses that may result from a dysregulation of this response. thetic and adrenomedullary (sympathetic) systems diseases.9 In turn, pro-inflammatory cytokines such
The molecular response to stress as IL-1b and tumour necrosis factor-a (TNF-a) activGlucocorticoids are the effectors of the HPA limb of ate NF-kB, thus perpetuating local inflammatory the stress system. Stress and non-stress activities of responses ( Figure 1 ).9 Glucocorticoids are potent glucocorticoids are regulated through two different inhibitors of the activation of NF-kB, which may types of glucocorticoid receptors. The type 1, highaccount for many of their anti-inflammatory actions. affinity or mineralocorticoid receptor (MR) mediates Generalized glucocorticoid resistance can result non-stress circadian fluctuations in glucocorticoids from quantitative or qualitative defects in the GR of and is primarily activational. The type 2, low-affinity a system.10 More recently, a polymorphism in the or glucocorticoid receptor (GR), mediates stress levels glucocorticoid receptor gene has been described of glucocorticoids, and is inhibitory in some systems which may result in increased glucocorticoid sensitivand activational in others.1 Glucocorticoid affinity ity.11 There are also numerous molecular determinfor the MR is 10 times that of the GR.2 Glucocorticoid ants of glucocorticoid sensitivity. receptors have a widespread distribution throughout tissues.
The glucocorticoid cytoplasmic receptor protein
The cellular response to stress belongs to the phylogenetically conserved superfamily of nuclear hormone receptors. 3 The receptor Glucocorticoids inhibit the functions of virtually all contains three major functional domains. The carboxyinflammatory cells (Table 1 ). This inhibition is mediterminal binds glucorticoid. This binding leads to the ated by altering the transcription of cytokine genes dissociation of heat-shock protein, which induces a (for example, TNF, IL-1, and IL-6), and by inhibiting conformational change in the glucocorticoid receptor the production of arachidonic-acid-derived promolecule. This, in turn, leads to nuclear translocation inflammatory substances such as leukotrienes and of the glucocorticoid receptor. In the nucleus, the prostaglandins.12 midregion binds to specific sequences of DNA Many substances activate the stress response. known as glucocorticoid-responsive elements (GREs).
Among these, TNF-a, IL-1, and IL-6 are the most This binding facilitates the activation of target genes important, and are produced at inflammatory sites by the aminoterminal sequence4 (Figure 1) . in a cascade-like fashion.13 These cytokines can Glucocorticoids may modulate immune responses stimulate the HPA-axis independently or synerin numerous ways, including through gene expresgistically. All three cytokines have autocrine effects sion, transcription, translation, post-translational proin that they stimulate their own secretion from the cessing, protein secretion, and cell progenitor cells that produce them. TNF-a and IL-1 proliferation and differentiation. Cytokine inhibition stimulate IL-6 secretion, but IL-6 inhibits TNF-a and accounts for many of the inhibitory effects on the IL-1 secretion.14 IL-6 acts synergistically with glucoimmune response during stress.
corticoids to stimulate the hepatic production of Glucocorticoids inhibit cytokine production by acute-phase proteins.15 altering mRNA stability at the level of gene expresGlucocorticoids inhibit the production of TNF-a, sion. Their actions may be mediated directly (Type IL-1, and IL-6, but there exists a hierarchy of sensitiv-1 mechanism) or indirectly (Type 2 mechanism).5 ity, with TNF having the greatest sensitivity and For example, glucocorticoids directly decrease transuppression occurring at physiological levels. IL-1 scription of the genes for interleukin-6 (IL-6) and has intermediate sensitivity, suppression occurring interleukin-1b, thus decreasing their production by only at supraphysiological levels, and IL-6 is relaimmune cells. In contrast, the immune response is tively resistant. Differential regulation of cytokine indirectly suppressed by glucocorticoids through production by type 1 and type 2 glucocorticoid inhibition of pro-inflammatory transcription factors receptors may explain this differential glucocorticoid such as nuclear factor-kB (NF-kB) and activating sensitivity.16 Glucocorticoids induce lympholysis protein-1 (AP-1).6 through 'apoptosis', or steroid-hormone-receptor-NF-kB is a heterodimer, which is found in the mediated cell death. This is mediated by the synthesis cytoplasm bound to IkBa and IkBb. These proteins of endogenous non-lysosomal endonucleases.17 prevent NF-kB from entering the nucleus.7 NF-kB is Lympholysis and redistribution of T-lymphocytes activated by many stressors (viral infection, oxidants, cause lymphopenia in the presence of corticocytokines, and antigens).8 Activation leads to the steroids.18 Glucocorticoids inhibit lymphocyte prolifrelease of IkB, allowing passage of NF-kB into the eration and activation by directly inhibiting IL-2 and nucleus, where it binds to specific sequences in the IL-2 receptor production, and by indirectly reducing promoter regions of target genes. NF-kB increases lymphocyte IL-2 synthesis through reduced monocyte the expression of the genes for many cytokines, IL-1 synthesis.19 Circulating monocytes and their secretion of IL-1, enzymes, and adhesion molecules in inflammatory Figure 1 . Cortisol binds to the glucocorticoid receptor/heat-shock protein (GR-HSP) complex in the cytoplasm, leading to the dissociation of heat shock protein (HSP), and the nuclear translocation of the glucocortiocid-glucocorticoid receptor complex. In the nucleus, the glucocortiocid-glucocorticoid receptor complex binds to glucocorticoid-responsive elements and activates target genes. This activation decreases transcription of certain genes (e.g. IL-1b/TNF genes), and increases transcription of other genes (e.g. IkB). Nuclear factor-kappa B (NF-kB) is bound to IkB in the cytoplasm. Activation signals such as cytokines lead to the dissociation of NF-kB from IkB, and the passage of NF-kB to the nucleus, where it increases the expression of genes for many cytokines, enzymes and adhesion molecules. These pro-inflammatory mediators further activate NF-kB in an amplifying loop, thus perpetuating local inflammatory responses. Glucocorticoids interrupt this process both by binding to activated NF-kB directly and preventing its nuclear binding, and by increasing the transcription of IkB, which also binds to activated NF-kB, further limiting its effects.
IL-6, TNF-a, and monocyte chemotactic-activating 1-activated endothelial cells.25 Eosinophil adherence to endothelial cells is reduced by IL-1 inhibition. factors are reduced by high concentrations of glucocorticoids.20−23 Impaired synthesis of collaBasophil numbers are reduced by 80% with higher concentrations of glucocorticoids, and the IgEgenase, elastase, and tissue plasminogen activator reduces the degradation of extracellular matrix and induced release of histamine and leukotrienes is impaired.26 Decreased T-lymphocyte cytokine fibrin by monocytes. 24 Glucocorticoids deplete both circulating and tissue release inhibits mast cell expansion, and endothelial adherence is also reduced.27,28 eosinophils. Eosinophil survival is reduced through inhibition of GM-CSF, which is produced by ILIn contrast, neutrophil concentrations rise in blood The neuroendocrine response to stress cholinergic systems of the brain and inhibited by the The central effectors of the stress response are the gamma-aminobutyric acid-benzodiazepine (GABAcorticotrophin-releasing hormone (CRH) and locus BDZ) and opioid peptide systems of the brain, as coeruleus-norepinephrine (LC-NE)/sympathetic syswell as by glucocorticoids, ACTH, and CRH itself.32 tems (Figure 2 ). CRH and noradrenergic neurons of ACTH and b-endorphin originate from the pituicyte the central stress system innervate and stimulate each and from arcuate nucleus POMC neurons, and are other in a positive feedback mechanism, such that involved in short negative feedback loops on the CRH activation of one system leads to activation of the system.42 other.31 CRH and norepinephrine collateral fibres In contrast to their central effects, CRH and AVP inhibit presynaptic CRH and a 1 -noradrenergic have pro-inflammatory effects at inflammatory sites, receptors respectively. 32 where immune cells and inflammatory exudates CRH is a 41-amino-acid peptide that is found in contain high concentrations of immunoreactive CRH the hypothalamus and many other brain regions, and CRH receptors.35,36 CRH has been detected in as well as the adrenal gland, placenta, ovary, the synovial fluid of patients with rheumatoid arthhuman lymphocyte, and at inflammatory sites.33−36 ritis, and in thyroid follicular cells of patients with Cytokines and inflammatory mediators stimulate autoimmune thyroiditis.43,44 CRH levels at inflammathypothalamic CRH release, which leads to pituitary ory sites may rise to concentrations similar to those adrenocorticotrophic (ACTH) hormone secretion into found in the hypophyseal portal system, but are the peripheral circulation.37 ACTH, in turn, leads to usually undetectable in the peripheral circulation adrenal glucocorticoid production and release.This during stress.36 Rapid uptake, catabolism, or binding adrenocorticosteroid response controls the immune may account for this gradient. Thus, CRH has response by inhibiting further cytokine procentral anti-inflammatory and opposing peripheral duction. CRH may also play a role in the onset of parturition, by triggering a surge in fetal cortisol. 38 pro-inflammatory effects. Figure 2 . The corticotrophin-releasing hormone (CRH) and locus coeruleus-norepinephrine (LC-NE) systems of the brain are the central effectors of the stress response, and participate in a positive reverbatory feedback loop, whereby activation of one tends to activate the other. The CRH system is inhibited by cortisol, substance P, GABA-BDZ, pro-opiomelanocortin (POMC) and other opioids, and CRH itself, and is activated by 5-hydroxytryptamine (5-HT), acetylcholine (ACh), the LC-NE sympathetic systems, arginine vasopressin (AVP), and inflammatory cytokines. Activation results in the production of CRH. CRH stimulates AVP secretion, and acts in synergy with AVP to stimulate pituitary adrenocorticotrophin (ACTH) release, which stimulates adrenal cortisol production. Tumour necrosis factor-a (TNF-a), interleukin-1 (IL-1), and IL-6 are produced from inflammatory sites in a cascade-like fashion, and are the most important activators of the CRH system. All three cytokines stimulate their own production. IL-1b and TNF stimulate IL-6 production, but IL-6 inhibits IL-1b and TNF production, and acts in concert with glucocorticoids to stimulate the hepatic secretion of acute-phase proteins. Glucocorticoids inhibit the production of all three cytokines, but TNF-a is the most sensitive, with IL-6 being relatively resistant. IFN-a, interferon-a; PAF, platelet-activating factor. Broken lines represent inhibition; Solid lines represent stimulation.
Cytokines inhibit growth hormone effects at target tissues by inhibiting insulin-like growth factor-1 (IGF-1) and However, IL-1 stimulates the production of endothelial cell prostaglandins (PGE2, PGI2), which in turn other growth factors. 55 The effects of stress on the growth axis may account for the delay in growth stimulate the secretion of CRH from nerve terminals in the median eminence, which lies outside the often seen in chronic disease and emotional deprivation in childhood. blood brain barrier.47 IL-1 may cross the blood-brain barrier at relatively leaky parts, such as the organum CRH, b-endorphin, and glucocorticoids inhibit GnRH secretion from the hypothalamus. vasculosum of the lamina terminalis, or during disease states such as infection or inflammation which Glucocorticoids also suppress pituitary gonadotrophin release and inhibit gonadal tissue.56 Patients may impair the barrier. IL-1 may also signal centrally via secondary messengers such as nitric oxide and with illnesses associated with increased HPA-axis activity, such as anorexia nervosa, hyperthyroidism, prostaglandins, or via the vagus and other nerves.48 IL-1, IL-6, and TNF, as well as other cytokines, and malnutrition, may experience abnormalities of menstrual and reproductive function.57−59 activate the HPA-axis, but this effect is blocked by glucocorticoids. 1 The CRH-stimulated increase in somatostatin inhibits TSH production and secretion. IL-6 also IL-6 is a potent stimulator of ACTH and cortisol secretion, leading to higher levels of these hormones inhibits the secretion of TSH.60 In the periphery, elevated circulating levels of glucocorticoid inhibit than are found with maximally-stimulating doses of CRH alone.49 This may result from ILthe conversion of T4 to T3. These changes lead to the characteristic biochemical picture of 'sick euthy-6-induced AVP secretion, which acts synergistically with CRH to produce higher ACTH levels.39 Also, roid' syndrome in patients with chronic stress system activation.61 IL-6 may act directly on the pituitary and adrenal glands, and may sensitise the adrenals to ACTH.50 At high doses, IL-6 increases plasma AVP levels, leading to suggestions that IL-6 may play a role in
The behavioural response to stress the syndrome of inappropriate ADH secretion. IL-6 also inhibits IL-1b and TNF-a production, and glucoBoth physical and emotional stressors activate homeostatic mechanisms. The CRH system is central corticoids up-regulate the expression of the IL-6 receptor.14,51 IL-6 production is resistant to glucocortto this process, and is found throughout the brain. The intraventricular administration of CRH in rats icoid suppression when compared to other cytokines.16 Thus, as well as being pro-inflammatory, leads to activation of the pituitary-adrenal axis and the sympathetic nervous system. This activation leads IL-6 may also have anti-inflammatory effects.
At high concentrations or with prolonged expoto increased blood glucose, heart rate, and blood pressure. Also, observation of the rats' behaviour sure, inflammatory cytokines can stimulate pituitary ACTH and adrenal cortisol secretion dirreveals increased arousal and vigilance, anorexia, reduced libido, changes in motor activity, and ectly.49 Cytokines may also induce glucocorticoid resistance. For example, the affinity of cortisol for increased tolerance of pain. 62 The stress response is intended to be of limited the glucocorticoid receptor is reduced in the presence of IL-2 and IL-4. T-cells obtained by bronchoalduration. In this way, its catabolic and immunosuppressive effects are homeostatic and without serveolar lavage from patients with glucocorticoidresistant asthma have high levels of IL-2 and IL-4 ious sequelae. Melancholic depression seems to represent an exaggerated and prolonged form of the gene expression, which result in glucocorticoid receptor binding defects. 52 hyperarousal seen with stress system activation, and patients with this condition show behavioural patterns that are similar in ways to rats treated with CRH.63,64 In these patients, cortisol excretion is
Other endocrine interactions increased, and the ACTH response to endogenous CRH is decreased.65 Bone mineral density may be Growth, reproductive function, and the thyroid axis are also influenced by stress system activation. In reduced, in keeping with a chronic hypercortisolaemic state. 66 The defect appears to be at or the acute setting of stress, glucocorticoids stimulate the growth hormone gene, leading to enhanced above hypothalamic level in hypercortisolaemic patients with melancholia, as evidenced by normal are also raised, as they are in the Lewis rat, and adrenal responses to surgery are blunted.76 Patients pituitary corticotroph function.63,64 Alterations in hippocampal serotonin 1A levels and in the mineralwith rheumatoid arthritis often experience symptoms of dysthymia, fatigue and depression. Although these ocorticoid/glucocorticoid receptor balance may be one of the methods by which stress may trigger and symptoms might be secondary to the disease process, they are also consistent with behavioural responses maintain depressive episodes. Other conditions associated with increased and prolonged activation of associated with a state of CRH deficiency, as seen in the Lewis rat. Patients with chronic fatigue synthe HPA axis include anorexia nervosa, obsessivecompulsive disorder and panic disorder. [67] [68] [69] drome also exhibit features of dysfunctional HPA axis activity, as evidenced by low 24-h urinary free In contrast, hypoactivation of the stress system/HPA axis, resulting in chronically cortisol and evening basal cortisol levels, in spite of attenuated but clear ACTH responses to CRH.73 reduced CRH secretion, may cause pathological hypoarousal. The Lewis rat provides an animal Treatment with low-dose hydrocortisone may improve fatigue in this condition.77 model wherein the hypofunctioning CRH neuron, and its consequent state of CRH deficiency, leads to Chronic HPA axis activation results in protective adaptation of the axis. For example, the immune susceptibility to inflammatory and autoimmune disease and abnormal behavioural responses. 70, 71 suppression seen in Cushing's disease is milder than would be expected for this degree of hypercortisolaeExamples of this HPA-axis hypoactivity in man include seasonal affective disorder, chronic fatigue mia. Hypothalamic substance P inhibits CRH secretion, and may be the substance explaining the syndrome, and nicotine withdrawal.72-74 CRH deficiency after nicotine withdrawal might account for inhibition of CRH neuron activity seen in inflammation.78 Also, inflammatory cytokines may block the the weight gain and hyperphagia seen in patients at this time. Similarly, CRH suppression from chronic stimulatory effects of CRH and ACTH on the pituitary and adrenal cortex.79 This is seen in septic hypercortisolaemia in Cushing's syndrome might explain the weight gain and hyperphagia that shock, AIDS, and African trypanosomiasis, in which adrenal responses to stress and ACTH are characterize this condition.
blunted.80−82 An excessive HPA axis response has been hypothesized to contribute to deterioration in memory,
Other disturbances in the system
resulting from prolonged exposure of hippocampal neurons to increased levels of glucocorticoids.83 The integrity of the immune response is central to resistance and susceptibility to inflammatory and Repeated and prolonged exposure to glucocorticoids causes hippocampal neurons to atrophy. However, behavioural syndromes.
An exaggerated HPA-axis response, as is seen in this atrophy may be a reversible phenomenon. Evidence for increased HPA-axis activity has been genetically CRH-hyper-responsive Fischer rats, and its consequent hypercortisolaemia, may increase susdemonstrated in patients with Alzheimer's type dementia.84 ceptibility to infection and tumours, but reduce susceptibility to inflammatory and autoimmune disPatients with systemic lupus erythematosis (SLE) exhibit high cortisol catabolism, and consequently ease. On the other hand, a blunted HPA-axis response and its consequent hypocortisolaemia may are corticosteroid-resistant when compared with other autoimmune diseases in terms of therapeutic enhance resistance to infection and tumours, but increase susceptibility to inflammatory and autosteroid requirement.85 Other diseases associated with resistance to glucocorticoids include steroid-resistant immune disorders. This state of CRH deficiency in the Lewis rat leads to increased susceptibility to asthma and AIDS. 86, 87 In contrast, essential hypertension has been associinflammatory disease, and abnormal behavioural responses similar to those seen in atypical depresated with a mild form of generalized glucocorticoid hypersensitivity. This may be due to an abnormally sion.70,71 AVP levels are chronically increased. Furthermore, reconstitution of the HPA-axis by hyposensitive glucocorticoid receptor, or to impaired 11-b-hydroxysteroid dehydrogenase activity, which thalamic transplantation from Fischer to Lewis rats virtually eradicates the Lewis rat peripheral inflamwould reduce cortisol metabolism at target organ level. In patients with sepsis, there is an increased matory response. 48 Early reports in humans show that HPA-axis abnorsensitivity to the antiproliferative actions of glucocorticoids.88 This hypersensitivity may be counteracted malities are also seen in autoimmune diseases such as rheumatoid arthritis. These patients have a blunted at the site of inflammation by high local concentrations of cytokines, which allows an adequate local circadian cortisol rhythm, and have inappropriately low or normal ACTH and cortisol levels, despite immune response in spite of elevated cortisol levels. The diurnal variation in cortisol concentration elevated TNF-a, IL-1b, and IL-6 levels.75 AVP levels CRH-specific mechanism,89 and could be therapeutic Peripherally, the inhibitory effect of IL-6 on TNFa and IL-1 production could be of therapeutic value 
